How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?
- DOI
- 10.1111/trf.70388
- Published
- 2026 Sep 19
- Container
- Transfusion
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/trf.70388,
title = {How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?},
author = {Bruneau L and Charlton CL and Ramirez-Arcos S and Kumaran D and Allan D and Norman O and Seftel M and Bloch EM and Pambrun C and O'Brien SF and Cranney C and Drews SJ},
year = {2026},
journal = {Transfusion},
doi = {10.1111/trf.70388},
url = {https://doi.org/10.1111/trf.70388}
}RIS
TY - JOUR TI - How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency? AU - Bruneau L AU - Charlton CL AU - Ramirez-Arcos S AU - Kumaran D AU - Allan D AU - Norman O AU - Seftel M AU - Bloch EM AU - Pambrun C AU - O'Brien SF AU - Cranney C AU - Drews SJ PY - 2026 JO - Transfusion DO - 10.1111/trf.70388 UR - https://doi.org/10.1111/trf.70388 ER -
APA
L, B., CL, C., S, R., D, K., D, A., O, N., M, S., EM, B., C, P., SF, O., C, C., & SJ, D. (2026). How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?. Transfusion. https://doi.org/10.1111/trf.70388
Source records
- pubmed · retrieved 2026-09-24T20:37:43.084Z